Convenience Kit Recall: Medical Action Industries Removes Convenience Kits Containing Namic RA Syringes

What Triggered the Recall?

Medical Action Industries (MAI) announced a voluntary recall of its Convenience Kits that include Namic RA syringes. The recall was initiated after reports of potential syringe seal failures that could lead to contamination or incorrect dosing.

Who Is Affected?

• Healthcare facilities that purchased MAI Convenience Kits between January 2024 and March 2025.
• Patients who received injections from the affected kits.

How to Identify the Affected Kits

Check the packaging for the following identifiers:

1. Batch number: NR-2024-07
2. Expiration date before 12/2026
3. Label stating “Namic RA – Convenience Kit”.

Steps to Take If You Have the Kit

Follow these three simple actions:

1. Stop using the kit immediately. Discontinue any further injections.
2. Contact your supplier or MAI’s customer service. Provide the batch number and expiration date.
3. Arrange for a safe return or disposal. MAI will cover shipping costs for the return.

Health Risks and What to Watch For

While no serious injuries have been reported yet, the potential risks include:

• Microbial contamination leading to infection.
• Inaccurate dosing that could reduce therapeutic efficacy.

If you notice redness, swelling, fever, or any unusual reaction at the injection site, seek medical attention right away.

MAI’s Response and Future Plans

Medical Action Industries has committed to:

• Conduct a thorough root‑cause analysis of the seal defect.
• Implement stricter quality‑control checks for future production runs.
• Provide a replacement kit or full refund to all affected customers.

How This Recall Impacts the Market

The recall highlights the growing scrutiny on injectable devices, especially as demand for home‑administered therapies rises. Clinics may now prioritize vendors with transparent post‑market surveillance and robust quality‑assurance programs.

Key Takeaways

• Verify batch numbers on all MAI Convenience Kits in your inventory.
• Stop using any kit that matches the recall criteria.
• Report any adverse events to your healthcare provider and to the FDA’s MedWatch program.

Conclusion

Staying proactive during a recall protects both patients and providers. By quickly identifying the affected Namic RA syringes and following MAI’s return instructions, you can minimize risk and ensure continuity of care.